Pharma

Innovation in digital health won’t come in a gradual, incremental way, but rather through dramatic re-imaginings of care.

McNeil Consumer Healthcare, the Johnson & Johnson subsidiary that makes over the counter medications like Tylenol and Zyrtec, has released a new mobile app, called Healthyday, that uses crowdsourced data to inform users about location-based allergy, cold, and flu trends.

While Teladoc has been pulling in a lot of press lately with its IPO news, competitor American Well has been busy too, securing an eight-figure investment from Israeli pharmaceutical giant Teva, according to a recent report in Israeli publication Globes.

San Diego, California-based Companion Medical, a stealthy medical device startup developing a Bluetooth-connected insulin pen and connected app, has closed its second round of funding, led by Eli Lilly and Company.

Swedish clinical trial recruitment company Trialbee has raised $5 million in first-round funding from existing investors Industrifonden and Briban Invest.

During Everyday Health's first quarter earnings call this week, CEO and Co-founder Ben Wolin pointed to strong growth in mobile marketing revenues for the health media company.

Iodine, the crowdsourced medication review company run by former Wired editor Thomas Goetz and former Google engineer Matt Mohebbi, is launching a new study this month to look specifically at the effects of antidepressants.

Pharma-related digital health news picked up this week.

A recent study published in the BMC Medicine medical journal concluded that smartphone apps that offer an insulin dose calculator may actively contribute to incorrect dose recommendations, according to the systematic assessment of 46 insulin dose calculator apps available on iOS and Android in the UK App Store.

Indianapolis-based pharma giant Eli Lilly is opening a new drug delivery and innovation center in Kendall Square in Cambridge, Massachusetts.